Isabel Fegers-Wustrow
Overview
Explore the profile of Isabel Fegers-Wustrow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mueller S, Dinges S, Gass F, Fegers-Wustrow I, Treitschke J, von Korn P, et al.
Nat Med
. 2025 Feb;
PMID: 39920395
Patients with coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM) have a substantially increased risk for major cardiovascular events and mortality. Increasing physical activity and improving a healthy...
2.
Edelmann F, Wachter R, Duvinage A, Mueller S, Fegers-Wustrow I, Schwarz S, et al.
Nat Med
. 2025 Jan;
31(1):306-314.
PMID: 39747684
Endurance exercise training (ET) is an effective treatment in heart failure with preserved ejection fraction (HFpEF), but the efficacy of resistance training in this patient population has been only scarcely...
3.
Mueller S, Kabelac M, Fegers-Wustrow I, Winzer E, Gevaert A, Beckers P, et al.
Eur J Prev Cardiol
. 2024 Oct;
PMID: 39453789
Aims: Exercise training (ET) is an effective therapy in heart failure with preserved ejection fraction (HFpEF), but the influence of different ET characteristics is unclear. We aimed to evaluate the...
4.
Mueller S, Fegers-Wustrow I, Halle M
JAMA
. 2023 Jun;
329(23):2095-2096.
PMID: 37338881
No abstract available.
5.
Bongiovanni D, Schreiner N, Gosetti R, Mayer K, Angiolillo D, Sibbing D, et al.
Arterioscler Thromb Vasc Biol
. 2022 Dec;
43(2):e83-e93.
PMID: 36546322
Background: Immature or reticulated platelets are associated with impaired efficacy of antiplatelet drugs and adverse events in cardiovascular patients. Their role as a predictive biomarker in patients with acute coronary...
6.
Tucker W, Fegers-Wustrow I, Halle M, Haykowsky M, Chung E, Kovacic J
J Am Coll Cardiol
. 2022 Sep;
80(11):1091-1106.
PMID: 36075680
Regular exercise that meets or exceeds the current physical activity guidelines is associated with a reduced risk of cardiovascular disease (CVD) and mortality. Therefore, exercise training plays an important role...
7.
Dinges S, Krotz J, Gass F, Treitschke J, Fegers-Wustrow I, Geisberger M, et al.
Diab Vasc Dis Res
. 2022 Aug;
19(4):14791641221113781.
PMID: 35953083
Background: Lifestyle interventions are a cornerstone in the treatment of chronic ischaemic heart disease (CIHD) and type 2 diabetes mellitus (T2DM). This study aimed at identifying differences in clinical characteristics...
8.
Mueller S, Haller B, Feuerstein A, Winzer E, Beckers P, Haykowsky M, et al.
ESC Heart Fail
. 2022 Jul;
9(5):3393-3406.
PMID: 35840541
Aims: Exercise training (ET) has been consistently shown to increase peak oxygen consumption (V̇O ) in patients with heart failure with preserved ejection fraction (HFpEF); however, inter-individual responses vary significantly....
9.
Niederdockl J, Simon A, Buchtele N, Schutz N, Cacioppo F, Oppenauer J, et al.
J Pers Med
. 2022 Apr;
12(4).
PMID: 35455660
Background: Modern personalised medicine requires patient-tailored decisions. This is particularly important when considering pharmacological cardioversion for the acute treatment of haemodynamically stable atrial fibrillation and atrial flutter in a shared...
10.
Fegers-Wustrow I, Gianos E, Halle M, Yang E
J Am Coll Cardiol
. 2022 Apr;
79(13):1304-1313.
PMID: 35361353
This review compares the primary prevention recommendations of the recent 2021 European Society of Cardiology (ESC) and 2019 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines on cardiovascular disease...